- Home
- MNKD vs ELME Comparison
MNKD vs ELME Comparison
Compare MNKD & ELME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- ELME
- Stock Information
- Founded
- MNKD 1991
- ELME 1960
- Country
- MNKD United States
- ELME United States
- Employees
- MNKD N/A
- ELME N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- ELME Real Estate Investment Trusts
- Sector
- MNKD Health Care
- ELME Real Estate
- Exchange
- MNKD Nasdaq
- ELME Nasdaq
- Market Cap
- MNKD 1.7B
- ELME 1.5B
- IPO Year
- MNKD 2004
- ELME N/A
- Fundamental
- Price
- MNKD $5.00
- ELME $16.67
- Analyst Decision
- MNKD Buy
- ELME Hold
- Analyst Count
- MNKD 6
- ELME 5
- Target Price
- MNKD $10.25
- ELME $15.00
- AVG Volume (30 Days)
- MNKD 4.3M
- ELME 1.4M
- Earning Date
- MNKD 11-05-2025
- ELME 10-23-2025
- Dividend Yield
- MNKD N/A
- ELME 4.28%
- EPS Growth
- MNKD 23.47
- ELME N/A
- EPS
- MNKD 0.10
- ELME N/A
- Revenue
- MNKD $313,787,000.00
- ELME $246,959,000.00
- Revenue This Year
- MNKD $14.78
- ELME N/A
- Revenue Next Year
- MNKD $19.36
- ELME N/A
- P/E Ratio
- MNKD $50.82
- ELME N/A
- Revenue Growth
- MNKD 17.43
- ELME 3.10
- 52 Week Low
- MNKD $3.38
- ELME $13.95
- 52 Week High
- MNKD $7.07
- ELME $18.08
- Technical
- Relative Strength Index (RSI)
- MNKD 39.71
- ELME 49.44
- Support Level
- MNKD $4.95
- ELME $16.59
- Resistance Level
- MNKD $6.24
- ELME $16.87
- Average True Range (ATR)
- MNKD 0.29
- ELME 0.19
- MACD
- MNKD -0.08
- ELME 0.02
- Stochastic Oscillator
- MNKD 4.26
- ELME 58.15
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About ELME Elme Communities
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.